Treatment of Erdheim-Chester disease with cladribine: a rational approach
- 1 June 2004
- journal article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 88 (6), 844-847
- https://doi.org/10.1136/bjo.2003.035584
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Interferon therapy for orbital infiltration secondary to Erdheim-Chester diseaseAmerican Journal of Ophthalmology, 2001
- Erdheim-Chester disease: Two cases of orbital involvementEye, 2000
- Cladribine activity in adult langerhans-cell histiocytosis.1999
- A phase I study of intermittent infusion cladribine in patients with solid tumorsCancer, 1994
- Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine.1994
- Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.Journal of Clinical Investigation, 1990
- Erdheim-chester disease. Case report and review of the literatureThe American Journal of Medicine, 1986
- Erdheim–Chester disease presenting as malignant exophthalmosThe British Journal of Radiology, 1986
- Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.Journal of Clinical Investigation, 1985
- Orbital manifestations of Erdheim-Chester disease.1983